Malignant Pleural Effusion: Diagnosis and Management

Symptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options (therapeutic thoracentesis, thoracoscopic ple...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucía Ferreiro, Juan Suárez-Antelo, José Manuel Álvarez-Dobaño, María E. Toubes, Vanessa Riveiro, Luis Valdés
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2020/2950751
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566173794828288
author Lucía Ferreiro
Juan Suárez-Antelo
José Manuel Álvarez-Dobaño
María E. Toubes
Vanessa Riveiro
Luis Valdés
author_facet Lucía Ferreiro
Juan Suárez-Antelo
José Manuel Álvarez-Dobaño
María E. Toubes
Vanessa Riveiro
Luis Valdés
author_sort Lucía Ferreiro
collection DOAJ
description Symptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options (therapeutic thoracentesis, thoracoscopic pleurodesis or thoracic drainage, indwelling pleural catheter, surgery, or a combination of these therapies). Despite the availability of therapies, the management of malignant pleural effusion is challenging and is mainly focused on the relief of symptoms. The therapy to be administered needs to be designed on a case-by-case basis considering patient’s preferences, life expectancy, tumour type, presence of a trapped lung, resources available, and experience of the treating team. At present, the management of malignant pleural effusion has evolved towards less invasive approaches based on ambulatory care. This approach spares the patient the discomfort caused by more invasive interventions and reduces the economic burden of the disease. A review was performed of the diagnosis and the different approaches to the management of malignant pleural effusion, with special emphasis on their indications, usefulness, cost-effectiveness, and complications. Further research is needed to shed light on the current matters of controversy and help establish a standardized, more effective management of this clinical problem.
format Article
id doaj-art-faf685b0b96047c0b0d6952ec4fdab56
institution Kabale University
issn 1198-2241
1916-7245
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-faf685b0b96047c0b0d6952ec4fdab562025-02-03T01:04:59ZengWileyCanadian Respiratory Journal1198-22411916-72452020-01-01202010.1155/2020/29507512950751Malignant Pleural Effusion: Diagnosis and ManagementLucía Ferreiro0Juan Suárez-Antelo1José Manuel Álvarez-Dobaño2María E. Toubes3Vanessa Riveiro4Luis Valdés5Pulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainSymptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options (therapeutic thoracentesis, thoracoscopic pleurodesis or thoracic drainage, indwelling pleural catheter, surgery, or a combination of these therapies). Despite the availability of therapies, the management of malignant pleural effusion is challenging and is mainly focused on the relief of symptoms. The therapy to be administered needs to be designed on a case-by-case basis considering patient’s preferences, life expectancy, tumour type, presence of a trapped lung, resources available, and experience of the treating team. At present, the management of malignant pleural effusion has evolved towards less invasive approaches based on ambulatory care. This approach spares the patient the discomfort caused by more invasive interventions and reduces the economic burden of the disease. A review was performed of the diagnosis and the different approaches to the management of malignant pleural effusion, with special emphasis on their indications, usefulness, cost-effectiveness, and complications. Further research is needed to shed light on the current matters of controversy and help establish a standardized, more effective management of this clinical problem.http://dx.doi.org/10.1155/2020/2950751
spellingShingle Lucía Ferreiro
Juan Suárez-Antelo
José Manuel Álvarez-Dobaño
María E. Toubes
Vanessa Riveiro
Luis Valdés
Malignant Pleural Effusion: Diagnosis and Management
Canadian Respiratory Journal
title Malignant Pleural Effusion: Diagnosis and Management
title_full Malignant Pleural Effusion: Diagnosis and Management
title_fullStr Malignant Pleural Effusion: Diagnosis and Management
title_full_unstemmed Malignant Pleural Effusion: Diagnosis and Management
title_short Malignant Pleural Effusion: Diagnosis and Management
title_sort malignant pleural effusion diagnosis and management
url http://dx.doi.org/10.1155/2020/2950751
work_keys_str_mv AT luciaferreiro malignantpleuraleffusiondiagnosisandmanagement
AT juansuarezantelo malignantpleuraleffusiondiagnosisandmanagement
AT josemanuelalvarezdobano malignantpleuraleffusiondiagnosisandmanagement
AT mariaetoubes malignantpleuraleffusiondiagnosisandmanagement
AT vanessariveiro malignantpleuraleffusiondiagnosisandmanagement
AT luisvaldes malignantpleuraleffusiondiagnosisandmanagement